
The Food and Drug Administration Center for Biologics Evaluation and Research Prevention has addressed new information that shipped vials of Pfizer’s BND162b2 mRNA COVID-19 vaccine contain extra doses, indicating that it is acceptable to use every full dose obtainable from each product vial.